Forbes uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person’s stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development. Microbiome Startup uBiome Expands into Drug Research with $83MXconomy A startup that’s helping us better understand the microbes that live in and on each of us is now going to start …CT Post |
Source:: Startup Tech News From Google News